NL-OMON20685
Not yet recruiting
Not Applicable
Influence of long term administration of fluoxetine on cerebral threshold and muscle activation patterns in chronic stroke.
Not provided0 sites28 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Not provided
- Enrollment
- 28
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •Chronic ischemic stroke patients (\> 6 months after stroke); age \> 18
Exclusion Criteria
- •1\. Patients suffering from another neurological disease;
- •2\. uncompensated hemineglect or cognitive disabilities;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Influence of long term administration of fluoxetine on cerebral threshold and muscle activation patterns in chronic strokeISRCTN46063747Rehabilitation Centre 'The Roessingh' Enschede (The Netherlands)28
Not yet recruiting
Phase 3
Influence of long-term administration of fluoxetine on cerebral threshold and muscle activity patterns in chronic stroke patients.cerebral vascular accidentstroke10007963NL-OMON30510Medisch Spectrum Twente34
Active, not recruiting
Not Applicable
Influence of long-term administration of fluoxetine on cerebral threshold and muscle activity patterns in chronic stroke patients. - Influence of fluoxetine on brain and muscle activity in chronic stroke patientsThe effect of fluoxetine on brain excitability and muscle activation will be measured in chronic stroke patients (> 6 months after stroke). As secondary measures, also brain activation, phase-synchronization in the brain, and motor function will be studied.MedDRA version: 8.1Level: LLTClassification code 10055221Term: Ischemic strokeEUCTR2006-005044-86-NLRoessingh Research and Development
Completed
Phase 3
Efficacy of Fluoxetine - a Trial in StrokeStrokeNCT02683213Karolinska Institutet1,500
Completed
Phase 3
Fluxetine AND Multiple Sclerosismultiple sclerosis.Demyelinating diseases of the central nervous systemIRCT2014052417811N2Arak University of Medical Science,Office of Vice Chancellor for Research58